Dear colleagues,
Please find attached a Health Alert on Xylazine and an accompanying flyer from the NJ Department of Health.
Xylazine is a veterinary tranquilizer not approved for human use which is increasingly prevalent in the illicit opioid supply in New Jersey. The Department is issuing this alert following increasing reports of xylazine-involved conditions throughout the state, including severe wounds, xylazine-involved overdose deaths, and heavy sedation following use.
These documents contain background information regarding xylazine, best practices for wound care and overdose response, and recommendations/resources for providers. Accompanying the Health Alert is a flyer for distribution to people who use drugs.
We appreciate your assistance with sharing this information widely. Should your organization be interested in further training on this topic, please reach out to Amanda Gan, Amanda.Gan@doh.nj.gov.
This information has been broadcast to: Community Organizations; Emergency Management; Local & County Government; Community Health Centers (FQHCs); Emergency Medical Services / First Responders; EMS Council; Long-term Care; Health Care Facilities / Other; Health Care Organizations; Health Care Providers; Hospital Staff Directory; Hospital CEOs; Hospital Emerg Preparedness Coords; Hospital ER Medical Directors; Hospital Infection Control Practitioners; Hospital Medical Directors; Hospital Nursing Directors; Hospital Patient Safety Liaisons; Hospital Quality Liaisons; Hospital Security Directors; ICU Administrator; Lab Director; Hospitals / Acute Care; Hospitals / Other; Hospitals / Veterans; LOCAL Boards of Health; Board of Public Utilities; Department of Children & Families; Department of Agriculture; Department of Community Affairs; Department of Corrections; Department of Education; Department of Environmental Protection; Department of Human Services; Department of Labor & Workforce Development; Department of Law and Public Safety; Department of Transportation; EMS Task Force; NJ Hospital Association; Office of Information Technology(OIT); Office of the Governor; New Jersey Departments & Agencies; DHSS Staff; NJDOH Staff; NJLINCS and Local Contacts; NJLINCS Community; Alabama; Alaska; American Samoa; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; District of Columbia; Federated State of Micronesia; Florida; Georgia; Guam; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Marshalls Island; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hamsphire; New Jersey; New Mexico; New York; North Carolina; North Dakota; North Mariana Islands; Ohio; Oklahoma; Oregon; Palau; Pennsylvania; Puerto Rico; Rhode Island; South Carolina; South Dakota; Tennnesse; Texas; Utah; Vermont; Virgin Islands; Virginia; Washington; West Virginia; Wisconsin; Wyoming; Other State Partners; Public Health Associations; Public Health Council; Public Health Sector; FQHC_1; FQHC_2; Harm_Reduction_Workers